Stoke Therapeutics, Inc. (STOK) KPIs and segments
STOKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30179% above fair value
$26.68+0.48 (+1.83%)
Close on Nov 13, 2026Market cap $1.72BP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Stoke Therapeutics's business
Coming soon
This tab will track the numbers specific to Stoke Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?